CSAR Benchmark Exercise 2011-2012: Evaluation of Results from Docking and Relative Ranking of Blinded Congeneric Series. - Kelly L. Damm-Ganamet; Richard D. Smith; James B. Dunbar Jr.; Jeanne A. Stuckey; Heather A. Carlson (J. Chem. Inf. Model., 2013)

CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys. - James B. Dunbar Jr.; Richard D. Smith; Kelly L. Damm-Ganamet; Aqeel Ahmed; Emilio Xavier Esposito; James Delproposto; Krishnapriya Chinnaswamy; You-Na Kang; Ginger Kubish; Jason E. Gestwicki; Jeanne A. Stuckey; Heather A. Carlson (J. Chem. Inf. Model., 2013)

CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma. - Heather A. Carlson; Richard D. Smith; Kelly L. Damm-Ganamet; Jeanne A. Stuckey; Aqeel Ahmed; Maire A. Convery; Donald O. Somers; Michael Kranz; Patricia A. Elkins; Guanglei Cui; Catherine E. Peishoff; Millard H. Lambert; et al. (J. Chem. Inf. Model., 2016)

CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking Challenge. - Richard D. Smith; Kelly L. Damm-Ganamet; James B. Dunbar Jr.; Aqeel Ahmed; Krishnapriya Chinnaswamy; James Delproposto; Ginger Kubish; Christine E. Tinberg; Sagar D. Khare; Jiayi Dou; Lindsey Doyle; Jeanne A. Stuckey; et al. (J. Chem. Inf. Model., 2016)

Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical Industry. - Kelly L. Damm-Ganamet; Nidhi Arora; Stephane Becart; James P. Edwards; Alec D. Lebsack; Heather M. McAllister; Marina I. Nelen; Navin L. Rao; Lori Westover; John J. M. Wiener; Taraneh Mirzadegan (J. Chem. Inf. Model., 2019)

The Need for Continuing Blinded Pose- and Activity Prediction Benchmarks. - Christian Kramer; John D. Chodera; Kelly L. Damm-Ganamet; Michael K. Gilson; Judith Guenther; Uta F. Lessel; Richard A. Lewis; David L. Mobley; Eva Nittinger; Adam Pecina; Matthieu Schapira; W. Patrick Walters (J. Chem. Inf. Model., 2025)